STERIS (STE) Earnings Analysis

STERIS (STE) has no confirmed upcoming earnings date. Last quarter (2026-05-11) it missed with EPS 2.83 USD vs 2.85 USD est (-0.7%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 26.49.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does STE next report earnings?

No confirmed upcoming earnings date is currently scheduled for STE. This page updates as the calendar is published.

STE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-112.83 USD2.85 USD-0.7%Miss
2026-02-042.53 USD2.53 USD0%Beat
2025-05-142.74 USD2.6 USD+5.4%Beat
2025-02-052.32 USD2.33 USD-0.4%Miss

Beat rate: 2/4 (50%) over reported quarters with consensus data.

STE valuation and analyst view

Trailing P/E26.49
Trailing EPS7.984 USD
Price / book2.87
Dividend yield1.20%
Market cap20.52B
Analyst consensusBuy (11 buy / 2 hold / 0 sell)
Avg price target269.5 USD

Related research pages

Frequently asked questions

When is STERIS (STE)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for STE. This page updates as the calendar is published.

Did STE beat earnings last quarter?

In its 2026-05-11 report, STE posted EPS of 2.83 USD versus a 2.85 USD estimate — a miss of 0.7%.

What is STE's earnings track record?

Over the last 4 reported quarters with consensus data, STE beat estimates 2 times (50%).

What is STE's current P/E ratio and EPS?

STE trades at a trailing P/E of 26.49 on trailing EPS of 7.983673469387755 USD.

What do analysts rate STE?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 11 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 269.5 USD.